Friday, May 18 is HIV Vaccine Awareness Day—time to reflect on the progress made in HIV prevention research and treatment and look ahead at ways of increasing community awareness and support.
As the home to the HIV Vaccine Trials Network (HVTN)—the largest clinical trials network for an HIV vaccine in the world—and the Statistical Center for HIV/AIDS Research and Prevention (SCHARP), the Hutchinson Center is on the frontline of the global fight to find a preventive vaccine against HIV.
"Every 10 minutes, someone in the United States is infected with HIV," said Dr. Jim Kublin, executive director, HVTN Core. "A preventive vaccine against HIV offers the best long-term hope to end this worldwide epidemic. Developing such a vaccine is also one of the world's greatest scientific challenges."
Get involved on HIV Vaccine Awareness Day
Community activities and media events will take place across in the country. Here are some things you can do locally.
Volunteers needed for HVTN 505 and other studies
The HVTN is currently running HVTN 505, the only active HIV vaccine efficacy trial in the United States. HVTN researchers seek to enroll a total of 2,200 men who have sex with men, and transgender women. The trial is enrolling participants in 18 cities, including Seattle, and needs 400 more participants nationally to meet the recruitment goal.
Volunteers at lower risk of HIV infection are needed for other studies.
For more information or to find out about eligibility to participate in a vaccine trial, please call the Seattle HIV Vaccine Trials Unit at (206) 667-2300 or visit www.seattlevaccines.org.